Sage Therapeutics to Present at Goldman Sachs 41st Annual Global Healthcare Conference
June 01 2020 - 6:30AM
Business Wire
Sage Therapeutics, Inc. (NASDAQ:SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, today announced that the Company will present at the Goldman
Sachs 41st Annual Global Healthcare Conference on Wednesday, June
10, 2020 at 3:00 p.m. ET.
A live webcast of the presentation can be accessed on the
investor page of Sage's website at investor.sagerx.com. A replay of
the webcast will also be archived for up to 30 days on Sage's
website following the conference.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel therapies with the potential to transform the
lives of people with debilitating disorders of the brain. We are
pursuing new pathways with the goal of improving brain health, and
our depression, neurology and neuropsychiatry franchise programs
aim to change how brain disorders are thought about and treated.
Our mission is to make medicines that matter so people can get
better, sooner. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200601005011/en/
Investors Jeff Boyle 347-247-5089
jeff.boyle@sagerx.com
Media Maureen L. Suda 617-949-4289
maureen.suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Apr 2023 to Apr 2024